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Dental caries is the most common reason behind a 
dental visit. The prevalence of dental caries across the 
globe is too high and restoration, commonly known 
as filling is the conventional treatment to repair 
damage caused by tooth decay wherein the procedure 
typically involves removing the damaged part of the 
tooth and replacing it with a restorative material 
which stays in the tooth and does not degrade. Thus, 
the normal mineral volume of the tooth is never 
restored completely. At late stages, when pulp is 
involved, time intensive root canal treatment is done. 
For teeth that cannot be saved by these treatment 
options, extraction is the only answer. The 
revolutions in biological and digital information are 
quickly converging with dental science and dentistry 
is at the threshold of new discoveries.1 
 
Glycogen synthase kinase-3 inhibitor have been 
studied as a potential therapeutic agents in 
depression, anxiety, schizophrenia, Alzheimer’s 
disease, supranuclear palsy, fragile X syndrome, 
multiple sclerosis, Parkinson’s disease, Huntington’s 
disease, stroke, traumatic brain injury, 
spinocerebellar ataxia type 1, sepsis, asthma, arthritis, 
colitis, peritonitis and various types of cancers.2 
These drugs have the capacity to modulate human 
stem cells in vivo. 
 
Tideglusib, a glycogen synthase kinase-3 inhibitor, 
initially tested for its role in Alzheimer’s disease and 
psychiatric disorders, has the potential to change the 
conventional treatment of dental caries owing to its 
property to regrow dentine to fill a void. Research 
suggests that this drug could help protect the inner 
layer by stimulating the production of the dentine 
allowing the tooth to repair itself. Zaugg LK et al., in 
their study on rat teeth, showed that Tideglusib can 
equally enhance reparative dentine formation to fully 
repair an area of dentine damage up to 10 times larger, 
mimicking the size of small lesions in human. In this 
research, Tideglusib treated teeth revealed 
significantly   more   mineralized    tissue   and  more  
dentine volume compared to the control group. The  
 
 
researchers were able to repair a surface damage area 
of 0.1 mm2 and volume of 0.055 mm3 completely.3 The 
mechanism behind this act of Tideglusib seems to be 
the activation of the Wnt/β-cat signaling pathway of 
resident mesenchymal stem cells from the tooth pulp 
wherein Axin 2 is a negative regulator and a 
downstream target.  The enzyme glycogen synthase 
kinase 3 is a prime cytoplasmic component of Wnt/β 
-cat signal transduction that phosphorylates Beta 
catenin and Axin, furthermore leading to 
ubiquitination and degradation.  This all happens in 
the absence of Wnt ligand/receptor binding. When 
these ligands are available, GSK-3 activity is inhibited 
and this allows Beta-catenin to enter the nucleus 
where it interacts with Lef/Tcf transcription factors 
and regulates the expression of the target genes 
including Axin2. The addition of Wnt signaling 
agonists provides an effective way to stimulate 
reparative formation of dentinal tissue and restores 
lost dentine with naturally generated new dentinal 
tissue.4 
 
The dental tissue produced by Tideglusib stimulation 
integrates itself completely with the enamel tissue 
which means the tooth is not only simply repaired 
and compensated but is regrown and restored back to 
health.5 
 
In a study conducted by del Ser et al., the use of 
Tideglusib was associated with mild to moderate 
adverse drug reactions, including transient increase 
in serum creatine kinase, ALT or gGT, diarrhea, 
nausea, cough, fatigue, and headache.6 Tideglusib is 
remarkably cheap and has a good safety profile 
making it more compliant with the subjects. 
 
Regenerative medicine aims to restore the original 
composition, functions and properties of lost tissues. 
A novel, biology based new generation treatment for 
dental caries is required. The use of Tideglusib is such 
an approach where dentinal restoration is stimulated 
via the mobilization of resident stem cells in the tooth 
pulp leading  to  the  formation  of  natural reparative  
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dentine. Promising potential for translational 
research approaches has been highlighted by use of 
tideglusib in animal studies. This property needs to 
be tested in human subjects respecting the ethical 
and regulatory criteria. Large scale clinical trial to 
explore the efficacy and safety of tideglusib in dental 
practice need to be designed and executed. 
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